150 related articles for article (PubMed ID: 38151289)
1. Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance.
Li AX; Zeng JJ; Khan E; Dou QP; Zhuang X; Ji EK; Ruge F; Martin TA; Jia S; Jiang WG
Cancer Genomics Proteomics; 2024; 21(1):30-40. PubMed ID: 38151289
[TBL] [Abstract][Full Text] [Related]
2. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
3. ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.
Yang YM; Ruge F; Ji KE; Jia S; Jia Y; Sanders AJ; Ji J; Jiang WG
Anticancer Res; 2023 Apr; 43(4):1463-1475. PubMed ID: 36974802
[TBL] [Abstract][Full Text] [Related]
4. Metastatic lymph node 64 (MLN64), a gene overexpressed in breast cancers, is regulated by Sp/KLF transcription factors.
Alpy F; Boulay A; Moog-Lutz C; Andarawewa KL; Degot S; Stoll I; Rio MC; Tomasetto C
Oncogene; 2003 Jun; 22(24):3770-80. PubMed ID: 12802284
[TBL] [Abstract][Full Text] [Related]
5. Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer.
Stigliano A; Gandini O; Cerquetti L; Gazzaniga P; Misiti S; Monti S; Gradilone A; Falasca P; Poggi M; Brunetti E; Aglianò AM; Toscano V
J Endocrinol; 2007 Jul; 194(1):55-61. PubMed ID: 17592021
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
Gao Y; Li S; Xu D; Chen S; Cai Y; Jiang W; Zhang X; Sun J; Wang K; Chang B; Wang F; Hong M
Chin J Cancer; 2017 Jul; 36(1):61. PubMed ID: 28754154
[TBL] [Abstract][Full Text] [Related]
7. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of metastatic lymph node ratio in gastric cancer.
Liu C; Lu P; Lu Y; Xu H; Wang S; Chen J
BMC Cancer; 2007 Oct; 7():200. PubMed ID: 17958880
[TBL] [Abstract][Full Text] [Related]
12. Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.
Wu ZM; Teng RY; Shen JG; Xie SD; Xu CY; Wang LB
J Int Med Res; 2011; 39(6):2086-95. PubMed ID: 22289523
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer.
Endo S; Ikenaga M; Yamada T; Tamura S; Sasaki YO
Anticancer Res; 2020 Apr; 40(4):2351-2357. PubMed ID: 32234937
[TBL] [Abstract][Full Text] [Related]
14. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
15. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
16. StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling.
Binh DHN; Cheng TC; Tu SH; Liao YC; Yang YY; Chen LC; Ho YS
Am J Cancer Res; 2023; 13(11):5151-5173. PubMed ID: 38058811
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
Oncol Rep; 2015 Oct; 34(4):1977-87. PubMed ID: 26239167
[TBL] [Abstract][Full Text] [Related]
18. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas.
Moog-Lutz C; Tomasetto C; Régnier CH; Wendling C; Lutz Y; Muller D; Chenard MP; Basset P; Rio MC
Int J Cancer; 1997 Apr; 71(2):183-91. PubMed ID: 9139840
[TBL] [Abstract][Full Text] [Related]
19. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
20. Involvement of three or more lymph nodes predicts poor prognosis in submucosal gastric carcinoma.
Shimada S; Yagi Y; Honmyo U; Shiomori K; Yoshida N; Ogawa M
Gastric Cancer; 2001; 4(2):54-9. PubMed ID: 11706761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
